#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Small intestine leiomyosarcoma Haemophilia B without inhibitors Immunoglobulin G4 related disease Hereditary ataxia Infection in an immunocompromised host Marfan's syndrome Hereditary optic atrophy X-linked lymphoproliferative syndrome Systemic mastocytosis Neoplasm Acute on chronic liver failure Pleomorphic liposarcoma Congenital megacolon Myeloid leukaemia Proteus syndrome More trials…

    Learn about Rare Diseases

    Haemophagocytic lymphohistiocytosis Lennox-Gastaut syndrome – Diagnostics Malignant fibrous histiocytoma – Diagnostics Leukoencephalopathy – Diagnostics Encephalitis autoimmune – Basic Information Sjogren’s syndrome Activated PI3 kinase delta syndrome Primary mediastinal large B-cell lymphoma – Trials in Disease SAPHO syndrome – Life with Disease Mast cell activation syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mk-2060 CHONDROITIN SULFATE SODIUM Clebopride Hydrogen Maleate Rilpivirine Levofloxacin Hemihydrate Darolutamide RNMB3 Anhydrous Cyclophosphamide Valproate Semisodium Lisaftoclax Ulipristal Acetate SURVODUTIDE IHMA-2121771-2 Festuca Rubra Pollen Venlafaxine Hydrochloride AAV9-CTNT-COBAG3 Deucrictibant Xanomeline Tartrate Xevinapant For-6219 More therapies…

    Learn about Your Condition

    Aplastic anaemia Asplenia Magnetic resonance imaging Breast angiosarcoma Hepatitis alcoholic Malignant melanoma of eyelid Intestinal ischaemia Fontan procedure Langerhans cell sarcoma Liposarcoma recurrent Pelizaeus-Merzbacher disease Mucosal inflammation Bacterial vaginosis Acarodermatitis Cytokine release syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Obesity

  • Study on the Effects of PF-07976016 and Liraglutide in Adults with Obesity

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Obesity
    • Overweight
    Investigated Drugs:
    • Liraglutide
    Hungary Poland

  • Study of AZD9550 and AZD6234 combination for weight loss in people with obesity or overweight with health complications

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Obesity
    • Overweight
    Investigated Drugs:
    • AZD6234
    • Azd9550
    • Calcium
    Germany

  • Study on Maintaining Weight Loss in Teens with Obesity Using Semaglutide

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Semaglutide
    Belgium Denmark France Germany Greece Italy +2

  • Study on the Long-term Weight Loss Effects of Cagrilintide and Semaglutide in Adults with Obesity

    Not recruiting

    3 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Cagrilintide
    • Semaglutide
    Belgium Denmark Portugal

  • Study on Semaglutide for Patients with Obesity and Resistant Hypertension to Improve Blood Pressure Control

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Semaglutide
    Ireland

  • Study to Evaluate the Effectiveness of Survodutide in Reducing Liver Fat and Weight in Patients with Obesity or Overweight and Non-Alcoholic Steatohepatitis (NASH)

    Not recruiting

    3 1
    Investigated Drugs:
    • BI 456906
    • SURVODUTIDE
    Germany The Netherlands Spain
Previous Page
1 … 11 12 13 14 15 … 18
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!